Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr
- 1 April 1997
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 179 (7) , 2189-2193
- https://doi.org/10.1128/jb.179.7.2189-2193.1997
Abstract
The Bacillus subtilis multidrug transporter Bmr, a member of the major facilitator superfamily of transporters, causes the efflux of a number of structurally unrelated toxic compounds from cells. We have shown previously that the activity of Bmr can be inhibited by the plant alkaloid reserpine. Here we demonstrate that various substitutions of residues Phe143 and Phe306 of Bmr not only reduce its sensitivity to reserpine inhibition but also significantly change its substrate specificity. Cross-resistance profiles of bacteria expressing mutant forms of the transporter differ from each other and from the cross-resistance profile of cells expressing wild-type Bmr. This result strongly suggests that Bmr interacts with its transported drugs directly, with residues Phe143 and Phe306 likely to be involved in substrate recognition.Keywords
This publication has 19 references indexed in Scilit:
- Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity.Proceedings of the National Academy of Sciences, 1996
- The role of the MDR protein in altered drug translocation across tumor cell membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active EffluxScience, 1994
- Multidrug resistance pumps in bacteria: variations on a themeTrends in Biochemical Sciences, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporterAntimicrobial Agents and Chemotherapy, 1993
- Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.Proceedings of the National Academy of Sciences, 1991
- An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) geneCell, 1988
- Interaction of Bacillus subtilis RNA polymerase with a chromosomal promoterJournal of Molecular Biology, 1982
- Ionization and divalent cation dissociation constants of nalidixic and oxolinic acidsBioinorganic Chemistry, 1978